Chin-Li Chen

Tri-Service General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Chin-Li Chen is a distinguished urologic oncologist whose research focuses on minimally invasive surgical techniques for upper urinary tract urothelial carcinoma (UTUC). His major contributions center on comparing the oncologic outcomes of robot-assisted nephroureterectomy (RANU) versus hand-assisted retroperitoneoscopic nephroureterectomy (HANU), with particular emphasis on perioperative circulating tumor cell (CTC) dynamics. In his landmark 2021 study, Chen demonstrated that surgical approach may influence CTC dissemination, providing critical insights into tumor biology during cancer surgery. With over 5 citations, this work has informed clinical decision-making in UTUC management. Chen’s research bridges the gap between surgical innovation and molecular oncology, helping to refine treatment paradigms for this rare but aggressive malignancy. His findings have been instrumental in advancing the understanding of how different surgical platforms affect cancer cell behavior, ultimately guiding surgeons toward approaches that minimize metastatic potential. Through his meticulous comparative studies, Chen continues to shape best practices in urologic oncology, making him a respected voice in the field of robotic surgery and cancer biomarker research.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Effects of robot-assisted versus hand-assisted nephroureterectomy on circulating tumor cells for upper urinary tract urothelial carcinoma
5 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Tri-Service General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago